These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 8467504)

  • 1. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
    Ling YH; Priebe W; Perez-Soler R
    Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
    Gruber BM; Anuszewska EL; Bubko I; Gozdzik A; Priebe W; Fokt I
    Anticancer Res; 2005; 25(3B):2193-8. PubMed ID: 16158963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
    Ling YH; Priebe W; Yang LY; Burke TG; Pommier Y; Perez-Soler R
    Cancer Res; 1993 Apr; 53(7):1583-9. PubMed ID: 8453627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
    Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
    Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
    Ramachandran C; You W; Krishan A
    Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internucleosomal DNA fragmentation in cultured cells under conditions reported to induce apoptosis may be caused by mycoplasma endonucleases.
    Paddenberg R; Wulf S; Weber A; Heimann P; Beck LA; Mannherz HG
    Eur J Cell Biol; 1996 Sep; 71(1):105-19. PubMed ID: 8884184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
    Mizumoto K; Rothman RJ; Farber JL
    Mol Pharmacol; 1994 Nov; 46(5):890-5. PubMed ID: 7969076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxic activity of 1-decarboxy-3-oxo-ceanothic acid in a human ovarian adenocarcinoma cell line.
    Su Y; Chang CL; Lee SS; Chen WC; Huang CF
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):313-26. PubMed ID: 9730010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
    Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
    Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
    Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
    Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA
    Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-induced DNA degradation in murine thymocytes.
    Zaleskis G; Berleth E; Verstovsek S; Ehrke MJ; Mihich E
    Mol Pharmacol; 1994 Nov; 46(5):901-8. PubMed ID: 7969078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis.
    Martin SJ; Lennon SV; Bonham AM; Cotter TG
    J Immunol; 1990 Sep; 145(6):1859-67. PubMed ID: 2167911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
    Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.
    De Isabella P; Capranico G; Binaschi M; Tinelli S; Zunino F
    Mol Pharmacol; 1990 Jan; 37(1):11-6. PubMed ID: 2153905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
    D'Alessandro N; Flugy A; Tolomeo M; Dusonchet L
    Anticancer Res; 1998; 18(4C):3065-72. PubMed ID: 9713511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.